Unique Ingredient Identifier B22547B95K is listed as a ingredient substance
| RN | 6132-04-3 |
| NCIT | C66642 |
| RXCUI | 221163 |
| PUBCHEM | 71474 |
| MF | C6H5O7.3Na.2H2O |
| INCHI KEY | NLJMYIDDQXHKNR-UHFFFAOYSA-K |
| SMILES | O.O.[Na+].[Na+].[Na+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O |
UNII B22547B95K TRISODIUM CITRATE DIHYDRATE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| IM - IV | INJECTABLE | 0.025 % |
| IM - IV | INJECTION | 24.75 MG/1ML |
| IM - IV | INJECTION | 2.5 % |
| IM - IV | SOLUTION | 0.025 % |
| IM - IV - SC | INJECTION | 0.21 % |
| IM - IV - SC | SOLUTION, INJECTION | 2.3 MG/1ML |
| IM - SC | INJECTION | 0.2 % |
| INHALATION | SOLUTION | 6.2 mg/3 mL |
| INHALATION | SOLUTION | 0.86 MG/INH |
| INHALATION | SOLUTION | 0.5 MG/ML |
| INHALATION | SUSPENSION, FOR INHALATION | 0.005 % |
| INTRA-ARTICULAR | INJECTION, SOLUTION | 11 mg/1mL |
| INTRACARDIAC | INJECTION | 10.35 mg/5mL |
| INTRAMUSCULAR | INJECTABLE | 8.1 mg/1mL |
| INTRAMUSCULAR | INJECTABLE | 8 % |
| INTRAMUSCULAR | INJECTION | 25.8 mg/1mL |
| INTRAMUSCULAR | INJECTION | 2.88 % |
| INTRAMUSCULAR | INJECTION, SOLUTION | 24.75 mg/1mL |
| INTRAMUSCULAR | INJECTION, SOLUTION | 0.025 %W/V |
| INTRAMUSCULAR | SOLUTION, INJECTION | 2.5 %W/V |
| INTRAOCULAR | INJECTION, SOLUTION, CONCENTRATE | 0.55 % |
| INTRAVENOUS | INJECTABLE | 8 % |
| INTRAVENOUS | INJECTABLE | 3.7 MG/1ML |
| INTRAVENOUS | INJECTION | 25.8 mg/1mL |
| INTRAVENOUS | INJECTION | 2.88 % |
| INTRAVENOUS | INJECTION, SOLUTION | 24.75 mg/1mL |
| INTRAVENOUS | INJECTION, SOLUTION | 0.16 % |
| INTRAVENOUS | LIQUID | 0.36 % |
| INTRAVENOUS | POWDER | 2.4 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 23.52 % |
| INTRAVENOUS | SOLUTION | 0.37 % |
| INTRAVENOUS | SOLUTION, INJECTION | 2.5 % |
| INTRAVENOUS INFUSION | INJECTION | 4 mg/1mL |
| INTRAVENOUS INFUSION | INJECTION | 0.03 % |
| INTRAVITREAL | SUSPENSION, INJECTION | 0.17 % |
| IRRIGATION | INJECTION, SOLUTION, CONCENTRATE | 0.55 % |
| IV(INFUSION) | INJECTABLE | 0.48 % |
| IV(INFUSION) | INJECTION | 0.48 % |
| IV(INFUSION) | INJECTION | 0.24 mg/1mL |
| IV(INFUSION) | SOLUTION, INJECTION | 3.04 % |
| NASAL | SPRAY | 1.44 % |
| NASAL | SPRAY, METERED | 680 MG/INH |
| NASAL | SPRAY, METERED | 0.28 % |
| OPHTHALMIC | SOLUTION | 4.47 MG/1ML |
| OPHTHALMIC | SOLUTION | 0.3 % |
| OPHTHALMIC | SOLUTION, DROPS | 2.94 mg/1mL |
| OPHTHALMIC | SOLUTION, DROPS | 0.45 % |
| ORAL | POWDER, FOR SUSPENSION | 1100 MG/140ML |
| ORAL | SOLUTION | 28 MG/5ML |
| ORAL | SOLUTION | 15.75 MG/1ML |
| ORAL | SOLUTION | 3.75 mg/15 mL |
| ORAL | SOLUTION, ELIXIR | 1.5 MG/5ML |
| ORAL | SOLUTION, ELIXIR | 0.047 %W/V |
| ORAL | SOLUTION, FOR INHALATION | 1 MG/.5ML |
| ORAL | SOLUTION, LIQUID | 3.3 MG/1ML |
| ORAL | SOLUTION, SYRUP | 59 MG/5ML |
| ORAL | SUSPENSION | 90 MG/5ML |
| ORAL | SUSPENSION | 0.04 mg/1mL |
| ORAL | SUSPENSION, FOR INHALATION | 1 MG/2ML |
| ORAL | SUSPENSION, LIQUID | 2.13 MG/1ML |
| ORAL | SYRUP | 55.24 MG/5ML |
| ORAL | SYRUP | 0.95 %W/W |
| ORAL | TABLET | 110 MG |
| ORAL | TABLET, EXTENDED RELEASE | 101 MG |
| PARENTERAL | INJECTION | 0.48 % |
| RESPIRATORY (INHALATION) | INHALANT | 0.2 % |
| RESPIRATORY (INHALATION) | SOLUTION, FOR INHALATION | 1.83 % |
| RESPIRATORY (INHALATION) | SUSPENSION, FOR INHALATION | 0.1 % |
| SUBCUTANEOUS | INJECTION | 10.35 mg/5mL |
| SUBCUTANEOUS | INJECTION | 0.2 % |
| SUBCUTANEOUS | INJECTION, SOLUTION | 0.2 % |
| SUBLINGUAL | FILM | 3.62 mg |
| SUBLINGUAL | TABLET | 17 MG |
| TOPICAL | CLOTH | 0.06 %W/W |
| TOPICAL | CREAM | 0.08 %W/W |
| TOPICAL | EMULSION, CREAM | 0.1 %W/W |
| TOPICAL | GEL | 0.14 %W/W |
| TOPICAL | LOTION | 0.32 %W/W |
| TOPICAL | OPHTHALMIC SUSPENSION DOSAGE FORM | 0.5 %W/V |
| TOPICAL | SHAMPOO | 2.67 %W/V |
| TOPICAL | SOLUTION | 4.47 MG/1ML |
| TOPICAL | SOLUTION | 0.3 %W/W |